We found that exogenous PDGF-BB did not disturb inhibitory effects of anti-TGF-β antibody on ERK1/2 and PAH PAVSMC proliferation, but prevented anti-TGF-β and anti-Activin A antibodies-dependent reduction in cell numbers. The gene discussed is TGFB1; the disease is pulmonary arterial hypertension.